Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart.

MLA

Dhat, Rohini, et al. “Epigenetic Modifier Alpha-Ketoglutarate Modulates Aberrant Gene Body Methylation and Hydroxymethylation Marks in Diabetic Heart.” Epigenetics & Chromatin, vol. 16, no. 1, Apr. 2023, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s13072-023-00489-4.

APA

Dhat, R., Mongad, D., Raji, S., Arkat, S., Mahapatra, N. R., Singhal, N., & Sitasawad, S. L. (2023). Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart. Epigenetics & Chromatin, 16(1), 1–20. https://doi.org/10.1186/s13072-023-00489-4

Chicago

Dhat, Rohini, Dattatray Mongad, Sivarupa Raji, Silpa Arkat, Nitish R. Mahapatra, Nishant Singhal, and Sandhya L. Sitasawad. 2023. “Epigenetic Modifier Alpha-Ketoglutarate Modulates Aberrant Gene Body Methylation and Hydroxymethylation Marks in Diabetic Heart.” Epigenetics & Chromatin 16 (1): 1–20. doi:10.1186/s13072-023-00489-4.